Vivante Health, Inc. is a digital health company focused on addressing digestive health and chronic conditions. Founded in 2016, it has developed GIThrive, a technology platform designed to provide actionable insights for managing digestive issues. GIThrive offers a comprehensive digital gut health program that includes expert guidance, 24/7 support, and personalized care plans. The company also provides GIMate, an innovative portable breathalyzer that identifies trigger foods, and GutCheck, which analyzes gut bacteria to recommend tailored diets. Vivante Health emphasizes individualized care, utilizing a scalable platform that integrates real-time data from biometric devices and partners. This approach not only aims to reduce healthcare costs and improve employee health for large employers and health plans but also enhances user empowerment through advanced science and technology. Headquartered in Houston, Texas, with an additional office in Athens, Greece, Vivante Health continues to prioritize innovative solutions in the realm of digestive health.
Axuall, Inc. provides digital network for verifying identity, credentials, and authenticity to healthcare, insurance, financial services, government, philanthropy, manufacturing, logistics, transportation, security, aviation, and construction sectors. The company was incorporated in 2018 and is headquartered in Cleveland, Ohio.
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions.
SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.
Recursion Pharmaceuticals is a biotechnology company based in Salt Lake City. Recursion combines experimental biology, automation, and artificial intelligence in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. From its initial and continued focus on drug repurposing to treat rare diseases, Recursion has broadened its platform to probe rich data from high-throughput automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. Recursion is aggressively leveraging technology to build a robust and reliable map of human cellular biology, which will enable a radical shift in the pace and scale at which new treatments will benefit patients.
GYANT.com, Inc. is a technology company based in Corte Madera, California, that specializes in developing an artificial intelligence-based chatbot application designed to enhance the connection between physicians and patients. The company's primary offering, the GYANT platform, assists healthcare providers by facilitating initial diagnostics, treatment recommendations, and prescription guidance through targeted patient inquiries. GYANT serves a variety of healthcare entities, including hospitals, health systems, and integrated delivery networks, aiming to streamline the patient experience. By implementing digital patient journeys, GYANT helps these organizations effectively capture new patients, improve service for existing ones, and automate various processes across their operations. Incorporated in 2016, GYANT focuses on creating solutions that navigate patients to appropriate care settings and in-network resources.
Syapse, Inc. is a company that specializes in precision medicine through its software platform, which integrates and analyzes clinical, molecular, treatment, and outcomes data. This platform supports data-driven decision-making for healthcare executives, care teams, and researchers involved in precision medicine programs. One of its key offerings is the Syapse Learning Health Network, a global data-sharing network focused on oncology, which leverages real-world data to enhance clinical decision-making. By connecting health systems, life sciences companies, and regulators, Syapse aims to accelerate the generation of real-world evidence to improve cancer patient outcomes. Founded in 2008 and headquartered in San Francisco, California, Syapse is committed to ensuring that all cancer patients receive high-quality care through improved precision medicine initiatives.
Omada Health, Inc. is a digital healthcare company that develops online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, the company collaborates with employers and health plans to identify individuals at risk for preventable chronic conditions such as prediabetes, diabetes, hypertension, and heart disease. Omada's programs are personalized to address the evolving needs of participants, offering support in areas like diabetes prevention, type 2 diabetes management, and behavioral health. The company integrates professional health coaching, connected health devices, real-time data, and personalized feedback to achieve clinically significant outcomes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program by the Centers for Disease Control and Prevention (CDC).
Armis, Inc. is a cybersecurity company that specializes in providing Internet of Things (IoT) security solutions. Founded in 2015 and headquartered in Palo Alto, California, with an additional office in Tel Aviv, Armis focuses on detecting and managing unmanaged and rogue devices within organizational networks. Its solutions protect enterprises from potential threats posed by various devices such as point of sale systems, medical devices, security cameras, printers, and other IoT applications. By offering an agentless security platform, Armis enables organizations to gain visibility and control over their IoT environments, thereby addressing critical security vulnerabilities across industries such as finance, healthcare, manufacturing, and technology.
Syapse, Inc. is a company that specializes in precision medicine through its software platform, which integrates and analyzes clinical, molecular, treatment, and outcomes data. This platform supports data-driven decision-making for healthcare executives, care teams, and researchers involved in precision medicine programs. One of its key offerings is the Syapse Learning Health Network, a global data-sharing network focused on oncology, which leverages real-world data to enhance clinical decision-making. By connecting health systems, life sciences companies, and regulators, Syapse aims to accelerate the generation of real-world evidence to improve cancer patient outcomes. Founded in 2008 and headquartered in San Francisco, California, Syapse is committed to ensuring that all cancer patients receive high-quality care through improved precision medicine initiatives.
Circulation, Inc. operates a platform that connects healthcare providers with the Uber driver network to facilitate transportation for patients and clinical trial participants. Founded in 2016 and based in Boston, Massachusetts, the company enhances logistical management in healthcare by offering a customizable digital platform that coordinates non-emergency transportation services. As Uber’s Preferred Healthcare Partner, Circulation aims to improve efficiency and health outcomes across the United States. The platform is designed for use by patients, caregivers, providers, staff, and volunteers, ensuring compliance with the Health Insurance Portability and Accountability Act (HIPAA) to safeguard patient privacy and security. Circulation's technology integrates seamlessly with Uber’s API and other ride providers, streamlining the transportation process within the healthcare ecosystem.